Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 14, 2021 - Issue
Submit an article Journal homepage
695
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017–2018

Yunlei Deng1 Department of Nephrology, The Chengdu Second Affiliated Hospital of Chongqing Medical University, The Third People’s Hospital of Chengdu, Chengdu, People’s Republic of ChinaView further author information
,
Qianwen Zhao2 Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
&
Rong Gong1 Department of Nephrology, The Chengdu Second Affiliated Hospital of Chongqing Medical University, The Third People’s Hospital of Chengdu, Chengdu, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 1751-1761 | Published online: 22 Apr 2021

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Qian Hu, Yao Chen, Ting Bao & Yan Huang. (2022) Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study. Renal Failure 44:1, pages 2006-2015.
Read now

Articles from other publishers (12)

Carolina M. Perdomo, Icíar Avilés-Olmos, Dror Dicker & Gema Frühbeck. (2023) Towards an adiposity-related disease framework for the diagnosis and management of obesities. Reviews in Endocrine and Metabolic Disorders.
Crossref
Nenny Agustanti, Nanny Natalia Mulyani Soetedjo, Fachreza Aryo Damara, Maria Riastuti Iryaningrum, Hikmat Permana, Muhamad Begawan Bestari & Rudi Supriyadi. (2023) The association between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 17:5, pages 102780.
Crossref
Mohammad Alomari, Mamoon Ur Rashid, Pravallika Chadalavada, Jonathan Ragheb, Hammad Zafar, Zoilo Karim Suarez, Shrouq Khazaaleh, Adalberto Jose Gonzalez & Fernando J Castro. (2023) Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes. World Journal of Hepatology 15:4, pages 477-496.
Crossref
Maria Sole Valentino, Pierluigi Marzuillo, Claudia Esposito, Mario Bartiromo, Michele Nardolillo, Annalisa Valentina Villani, Alessandro Maresca, Giuseppe Furcolo, Stefano Guarino, Emanuele Miraglia del Giudice & Anna Di Sessa. (2023) The Impact of COVID-19 Pandemic Lockdown on the Relationship between Pediatric MAFLD and Renal Function. Journal of Clinical Medicine 12:5, pages 2037.
Crossref
Canxia Shi, Sanne de Wit, Emina Učambarlić, George Markousis-Mavrogenis, Elles Screever, Wouter Meijers, Rudolf de Boer & Joseph Aboumsallem. (2023) Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms. Cancers 15:3, pages 729.
Crossref
Rosaria Maria Pipitone, Carlo Ciccioli, Giuseppe Infantino, Claudia La Mantia, Stefanie Parisi, Adele Tulone, Grazia Pennisi, Stefania Grimaudo & Salvatore Petta. (2023) MAFLD: a multisystem disease. Therapeutic Advances in Endocrinology and Metabolism 14, pages 204201882211455.
Crossref
Panagiotis Theofilis, Aikaterini Vordoni & Rigas G Kalaitzidis. (2022) Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations. World Journal of Gastroenterology 28:39, pages 5691-5706.
Crossref
Alessandro Mantovani, Rosa Lombardi, Filippo Cattazzo, Chiara Zusi, Davide Cappelli & Andrea Dalbeni. (2022) MAFLD and CKD: An Updated Narrative Review. International Journal of Molecular Sciences 23:13, pages 7007.
Crossref
Arnab Banerjee, Sandip Mukherjee & Bithin Kumar Maji. (2022) Coccinia grandis alleviates flavor‐enhancing high‐lipid diet induced hepatocellular inflammation and apoptosis . Journal of Food Biochemistry 46:5.
Crossref
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, Giovanni Targher, Christopher D. Byrne, Dan-Qin Sun & Ming-Hua Zheng. (2022) Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nature Reviews Nephrology 18:4, pages 259-268.
Crossref
Yoshitaka Hashimoto, Masahide Hamaguchi, Takuro Okamura, Naoko Nakanishi, Akihiro Obora, Takao Kojima & Michiaki Fukui. (2021) Metabolic associated fatty liver disease is a risk factor for chronic kidney disease. Journal of Diabetes Investigation 13:2, pages 308-316.
Crossref
Luciana Marc, Adelina Mihaescu, Raluca Lupusoru, Iulia Grosu, Florica Gadalean, Flaviu Bob, Lazar Chisavu, Nicu Olariu, Vlad Tucicovschi, Bogdan Timar, Ioan Sporea, Romulus Timar & Adalbert Schiller. (2022) Liver Steatosis: Better Predictor of CKD in MAFLD Than Liver Fibrosis as Determined by Transient Elastography With Controlled Attenuation Parameter. Frontiers in Medicine 8.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.